Cargando…

Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma

Glioblastoma (GBM) is the most malignant CNS tumor with a highest incidence rate, and most patients would undergo a recurrence. Recurrent GBM (rGBM) shows an increasing resistance to chemotherapy and radiotherapy, leading to a significantly poorer prognosis and the urgent need for novel treatments....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Binghao, Wu, Jiaming, Li, Huanzhang, Wang, Yuekun, Wang, Yaning, Xing, Hao, Wang, Yu, Ma, Wenbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091563/ https://www.ncbi.nlm.nih.gov/pubmed/37046332 http://dx.doi.org/10.1186/s12964-023-01098-0

Ejemplares similares

Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
por: Zhao, Binghao, et al.
Publicado: (2022)

Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-Analysis
por: Chen, Wenlin, et al.
Publicado: (2021)

Prognostic Prediction Model for Glioblastoma: A Metabolic Gene Signature and Independent External Validation
por: Lei, Chuxiang, et al.
Publicado: (2021)

Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis
por: Zhao, Binghao, et al.
Publicado: (2021)

Molecular landscape of IDH-mutant astrocytoma and oligodendroglioma grade 2 indicate tumor purity as an underlying genomic factor
por: Zhao, Binghao, et al.
Publicado: (2022)

Palliative care for patients with glioma: A recent scientometric analysis of the Web of Science in 2022
por: Xiao, Zhiyuan, et al.
Publicado: (2022)

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023)

Characteristic analysis and identification of novel molecular biomarkers in elderly glioblastoma patients using the 2021 WHO Classification of Central Nervous System Tumors
por: Wang, Yaning, et al.
Publicado: (2023)

Comprehensive ability evaluation and trend analysis of patients with malignant intracranial tumors in the perisurgery period
por: Wang, Yaning, et al.
Publicado: (2021)

Tumor-Treating Fields in Glioblastomas: Past, Present, and Future
por: Guo, Xiaopeng, et al.
Publicado: (2022)

Current evidence and challenges of systematic therapies for adult recurrent glioblastoma: Results from clinical trials
por: Chen, Wenlin, et al.
Publicado: (2021)

Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients
por: Wang, Zihao, et al.
Publicado: (2021)

Immunotherapy of glioblastoma: Recent advances and future prospects
por: Yuan, Boyang, et al.
Publicado: (2022)

Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses
por: Zhao, Binghao, et al.
Publicado: (2020)

Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress
por: Wang, Yaning, et al.
Publicado: (2021)

Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors
por: Chen, Wenlin, et al.
Publicado: (2023)

Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023)

Novel insight into histological and molecular astrocytoma, IDH‐mutant, Grade 4 by the updated WHO classification of central nervous system tumors
por: Chen, Wenlin, et al.
Publicado: (2023)

Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects
por: Pineda, Estela, et al.
Publicado: (2023)

NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma
por: Wang, Yuekun, et al.
Publicado: (2020)

Safe surgery for glioblastoma: Recent advances and modern challenges
por: Gerritsen, Jasper Kees Wim, et al.
Publicado: (2022)

Biosensors—Recent Advances and Future Challenges
por: Bollella, Paolo, et al.
Publicado: (2020)

Challenges and Recent Advancements in COVID-19 Vaccines
por: Wang, Shao-Cheng, et al.
Publicado: (2023)

A novel hypoxic tumor microenvironment signature for predicting the survival, progression, immune responsiveness and chemoresistance of glioblastoma: a multi-omic study
por: Wang, Zihao, et al.
Publicado: (2020)

Human brucellosis: recent advances and future challenges
por: O’Callaghan, David
Publicado: (2020)

Development of a nomogram for prognostic prediction of lower‐grade glioma based on alternative splicing signatures
por: Wang, Yaning, et al.
Publicado: (2020)

Honokiol in glioblastoma recurrence: a case report
por: Wang, Ce, et al.
Publicado: (2023)

The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma
por: Neth, Bryan J., et al.
Publicado: (2023)

Recent advances and challenges of bispecific antibodies in solid tumors
por: Wu, Yuze, et al.
Publicado: (2021)

Recent Advances and Future Challenges in the Genetics of Multiple Sclerosis
por: Lill, Christina M.
Publicado: (2014)

Biosensors—Recent Advances and Future Challenges in Electrode Materials
por: Otero, Fernando, et al.
Publicado: (2020)

Recent Advances and Future Challenges in the Additive Manufacturing of Hydrogels
por: Danek, Chris
Publicado: (2022)

Recent Advances and Future Challenges in the Field of Digestive Diseases
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Recent Understanding and Future Directions of Recurrent Corticotroph Tumors
por: Hinojosa-Amaya, José Miguel, et al.
Publicado: (2021)

Recent Advances in Cotton Genomics
por: Zhang, Hong-Bin, et al.
Publicado: (2008)

Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges
por: Liu, Zhaoyuan, et al.
Publicado: (2021)

Immunotherapy for recurrent glioblastoma: practical insights and challenging prospects
por: Wang, Xin, et al.
Publicado: (2021)

Genome Editing in Rice: Recent Advances, Challenges, and Future Implications
por: Mishra, Rukmini, et al.
Publicado: (2018)

Spectrum Sensing for Cognitive Radio: Recent Advances and Future Challenge
por: Nasser, Abbass, et al.
Publicado: (2021)

Ransomware: Recent advances, analysis, challenges and future research directions
por: Beaman, Craig, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_66dp219m8mngeanf01gnfshdmb